Wednesday, April 29, 2020

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump

Glenmark Pharma to conduct trials for potential COVID-19 drug, shares jump Favipiravir, manufactured under the brand name Avigan by a unit of Japan#39;s Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

from Moneycontrol Business News https://ift.tt/3bQ2Kd5

No comments:

Post a Comment

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...